tiprankstipranks
Trending News
More News >
Molecular Partners AG (CH:MOLN)
:MOLN

Compare Molecular Partners AG (MOLN) vs. Competitors

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Molecular Partners AG
CHF3.56
CHF141.92M
-2.20
-20.69%
0 Buy
1 Hold
0 Sell
Hold
Idorsia Ltd
CHF3.62
CHF929.20M
-5.24
404.32%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF19.76
CHF395.49M
15.75
93.44%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF12.64
$180.10M
-2.47
-25.03%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF20.60
CHF121.12M
3.97
-2.73%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:MOLN
Molecular Partners AG
3.57
-0.90
-20.07%
CH:IDIA
Idorsia Ltd
3.51
2.80
400.71%
CH:NWRN
Newron Pharmaceuticals SpA
18.86
8.76
86.73%
CH:SANN
Santhera Pharmaceuticals Holding
12.64
-4.08
-24.40%
CH:RLF
CH:XLS
Xlife Sciences Ltd.
21.40
0.20
0.94%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts